Atara Biotherapeutics, Inc.·4

Feb 12, 8:54 PM ET

MCGRATH JOHN 4

4 · Atara Biotherapeutics, Inc. · Filed Feb 12, 2018

Insider Transaction Report

Form 4
Period: 2018-02-09
MCGRATH JOHN
Chief Financial Officer
Transactions
  • Tax Payment

    Common Stock

    2018-02-09$41.70/sh4,819$200,952105,556 total
Footnotes (1)
  • [F1]Shares withheld to cover tax obligation from settlement of vested restricted stock units.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION